Funding Opportunities and Announcements

HRSA Announces FY 2022 Ending the HIV Epidemic - Primary Care HIV Prevention (PCHP) Competitive Funding Opportunity for Health Centers

Notice of Intent to Publish a Funding Opportunity Announcement for Adolescent Medicine Trials Network for HIV/AIDS Intervention (ATN) Scientific Leadership Center (UM2 Clinical Trial Required), and Operations and Collaborations Center (UM1 Clinical Trial)

PHACS Emerging Research Pilot (ERP) Program

Expanding Differentiated Care Approaches for Adolescents Living with HIV (R01 Clinical Trial Optional)

Expanding Differentiated Care Approaches for Adolescents Living with HIV (R34 Clinical Trial Optional)

Notice of Special Interest (NOSI): Examining Effects of HIV Pre-Exposure Prophylaxis (PrEP) on Heart, Lung, Blood, and Sleep Function

Effectiveness of School-Based Health Centers to Advance Health Equity (R01 Clinical Trial Optional)

Limited Competition: Development and Renovation of Research Space for HIV/AIDS Research at Institutions Serving Underrepresented Populations or Located in Institutional Development Award (IDeA)-eligible States (C06 Clinical Trial Not Allowed)

NIMH Research Education Mentoring Program for HIV/AIDS Researchers (R25 Clinical Trial Not Allowed)

Four New Funding Opportunities, Rapid Acceleration of Diagnostics (RADX) Related to COVID-19 Testing

Health Services Research on Minority Health and Health Disparities (R01- Clinical Trial Optional)  

Advancing HIV/AIDS Research within the Mission of the NIDCD (two opportunities), standard AIDS dates apply. Expires in 2023:

• R21 Clinical Trial Optional
• R01 Clinical Trial Optional

NIDA Avant-Garde Award Program for HIV/AIDS and Substance Use Disorder Research (DP1, Clinical Trial Optional)

Mid-Career Enhancement Awards to Integrate Basic Behavioral, Biomedical, and/or Social Scientific Processes (K18 No Independent Clinical Trials)

Developmental Centers for AIDS Research (P30 Clinical Trial Not Allowed)